Nuveen Asset Management’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-102,702
| Closed | -$233K | – | 3345 |
|
2024
Q1 | $233K | Hold |
102,702
| – | – | ﹤0.01% | 3151 |
|
2023
Q4 | $301K | Buy |
102,702
+2,914
| +3% | +$8.54K | ﹤0.01% | 3146 |
|
2023
Q3 | $422K | Hold |
99,788
| – | – | ﹤0.01% | 2898 |
|
2023
Q2 | $875K | Buy |
+99,788
| New | +$875K | ﹤0.01% | 2706 |
|
2022
Q2 | – | Sell |
-26,322
| Closed | -$3.11M | – | 3256 |
|
2022
Q1 | $3.11M | Hold |
26,322
| – | – | ﹤0.01% | 2300 |
|
2021
Q4 | $3.11M | Sell |
26,322
-12,500
| -32% | -$1.48M | ﹤0.01% | 2359 |
|
2021
Q3 | $4.58M | Sell |
38,822
-518
| -1% | -$61.2K | ﹤0.01% | 2264 |
|
2021
Q2 | $3.64M | Buy |
+39,340
| New | +$3.64M | ﹤0.01% | 2407 |
|